Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Fingolimod 0.5 mg capsules vs Gilenya in healthy Thai volunteers under fasting
TCTR20200314004Phase 0Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of fingolimod (2 arms), sponsored by Bio-innova. Planned start May 2020; status: not yet recruiting.
02
Drugs
fingolimod
Beyond the preview
Go deeper on TCTR20200314004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200314004.